Psoriatic arthritis
Dr John Bowes and Dr Gisela Orozco reveal how genetic investigations will transform outcomes for people with psoriatic arthritis in the future
Scientists are always on the lookout for new psoriatic arthritis treatments. And the rapidly evolving field of genetics is throwing up some exciting new findings that could make a huge difference to the quality of life of people affected.
Continue reading
Psoriatic arthritis drug risankizumab improves skin and joints in the long-term, trial suggests
Treatment with risankizumab can work well for people with psoriatic arthritis on a long-term basis, says research presented at a European conference.Moderna vs Pfizer vaccine for COVID for the immunocompromised
The Moderna vaccine for COVID-19 appears to elicit a stronger response in people with immunosuppression than the Pfizer vaccine says research in a leading journal.
Exercise in water to take on inflammatory arthritis symptoms, experts advise after new evidence review
Aquatic exercise is effective in treating pain, disease activity and function in people with inflammatory arthritis says a large review of the evidence.
Tick saliva protein (Votucalis) could be developed into chronic pain drug
A protein found in tick saliva may soon be turned into a drug that eases both chronic pain and chronic itching. It is hoped that the protein – called Votucalis – could lead to a replacement for traditional painkillers, for example opioids, that can be ineffective, have serious side-effects and are addictive.
